filmov
tv
Manitoba woman defeats Stage 4 cancer with new CAR T-cell therapy
Показать описание
“It’s like a bullet. You hear cancer and you just go blank. It was my worst fear," Sandra Hajlo recalled hearing her diagnosis for the first time. Hajlo was diagnosed with stage four B-cell lymphoma in 2015. She immediately began chemotherapy in Winnipeg. After six months, fist-sized tumor had disappeared, and she was declared cancer-free. But eight years later, the pain returned.
Hajlo said her doctor believed she was suffering from scoliosis, but ordered a CT scan “just to confirm.” She began chemotherapy at CancerCare Manitoba once again. But then, her oncologist approached her about a different kind of treatment. Hajlo met the criteria to undergo chimeric antigen receptor, or CAR T-cell therapy. She would be the first person treated with this therapy by CancerCare Manitoba.
“You have a group of patients who, historically, would not have been cured of their disorder, who appear to be in remission in the several years after the procedure,” he said. “And we think there’s a proportion of those people who are definitely cured of their cancer.” said Dr. David Szwajcer, Manitoba Blood & Marrow Transplant Director with CancerCare Manitoba.
For patients like Hajlo, that care meant a second chance at life. After receiving CAR T-cell therapy in December 2023, she learned Wednesday that the treatment worked, and that she is cancer-free for a second time.
#GlobalNews
Hajlo said her doctor believed she was suffering from scoliosis, but ordered a CT scan “just to confirm.” She began chemotherapy at CancerCare Manitoba once again. But then, her oncologist approached her about a different kind of treatment. Hajlo met the criteria to undergo chimeric antigen receptor, or CAR T-cell therapy. She would be the first person treated with this therapy by CancerCare Manitoba.
“You have a group of patients who, historically, would not have been cured of their disorder, who appear to be in remission in the several years after the procedure,” he said. “And we think there’s a proportion of those people who are definitely cured of their cancer.” said Dr. David Szwajcer, Manitoba Blood & Marrow Transplant Director with CancerCare Manitoba.
For patients like Hajlo, that care meant a second chance at life. After receiving CAR T-cell therapy in December 2023, she learned Wednesday that the treatment worked, and that she is cancer-free for a second time.
#GlobalNews
Комментарии